Itsa wrote: “Has ANP notified Arcturus that blood results can further their research into long covid?”
Okay, I’m not medically trained but this statement reeks of further questioning.
1. Unless you know upthedell works for ANP, how would he/she
or anyone else here know who ANP has contacted if it’s not in a company announcement?
2. Why would ANP be contacting Arcturus (ARCT) to tell them something that is probably bioscience101 and is none of ANP’s business?
3. Unless I’m mistaken, ARCT are working on mRNA vaccines for Covid (among other disease research). IMHO one doesn’t develop a vaccine specifically for Long Covid, it’s a sequelae of Covid.
ANP - Interesting general news items in BIO, page-4
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
-0.001(1.33%) |
Mkt cap ! $66.71M | |||
| Open | High | Low | Value | Volume |
| 7.5¢ | 7.5¢ | 7.2¢ | $49.57K | 678.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 141155 | 2 |
View Market Depth
| Last trade - 14.44pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
-0.001 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 7.3¢ | 7.4¢ | 7.2¢ | 151427 | ||
| Last updated 14.47pm 30/05/2024 ? | |||||
| PER (ASX) Chart |